Get the app
Healthcare2 min reading time

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Ars Technica
Read the full article
Moderna's mRNA flu vaccine, mFLUSIVA, has received FDA approval, marking a milestone for mRNA technology in flu prevention. The vaccine offers faster production and potential benefits over traditional flu shots but faces uncertainty due to a stalled CDC advisory panel and unclear insurance coverage.
#cdc#fda#influenza-vaccination#mflusiva#moderna#mrna-vaccines

More in Healthcare

Healthcare32 min read

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Nature
Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)